{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:26Z","timestamp":1787028566025,"version":"build-2736575974"},"reference-count":113,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education of the Russian Federation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Currently, there is no standard treatment for renal cell carcinoma (RCC) that is free of side effects and resistance. Additionally, limited information exists on how curcumin affects the gene expression profiles of patients with translocation renal cell carcinoma (tRCC) and papillary renal cell carcinoma (pRCC). The pathways responsible for metastasis in tRCC are still not well understood, and there is no established treatment or reliable biomarker to predict outcomes for metastatic tRCC. Primary clinical data from patients were retrieved from the TCGA database and analyzed using cBioPortal, stitch, string, R and Python. Various analyses were performed, including differential gene expression, protein-protein interaction (PPI) network analysis, drug-targeted gene analysis, gene ontology (GO), enrichment analyses, and systematic searches to assess the impact of curcumin on the transcriptomic profiles of tRCC, pRCC, and clear cell renal cell carcinoma (ccRCC). No significant impact of sensitive genes on survival in KIRC and KIRP was found, though a trend suggested they may delay disease progression. The combination of curcumin with sunitinib showed promise in overcoming drug resistance in ccRCC by inducing ferroptosis, reducing iron, and increasing ADAMTS18 expression. This study, leveraging data from the TCGA database and other databases explored the impact of curcumin on transcriptomic profiles in tRCC, pRCC, and clear cell RCC (ccRCC). Gene analysis revealed immune and metabolic differences, with KIRC showing a stronger immune response. This study is the first to propose that future research into the miR-148\/ADAMTS18 genes and the ferroptosis pathway in tRCC and pRCC could lead to the development of new therapies and the identification of novel therapeutic targets, potentially overcoming drug resistance and metastasis.<\/jats:p>","DOI":"10.3390\/ijms26136161","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T03:33:25Z","timestamp":1750995205000},"page":"6161","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparative Transcriptomics Study of Curcumin and Conventional Therapies in Translocation, Clear Cell, and Papillary Renal Cell Carcinoma Subtypes"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9439-1302","authenticated-orcid":false,"given":"Moses Owoicho","family":"Abah","sequence":"first","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"},{"name":"Department of Cancer Bioinformatics and Molecular Biology, Royal Society of Clinical and Academic Researchers (ROSCAR) International, Abuja 900104, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3058-0005","authenticated-orcid":false,"given":"Deborah Oganya","family":"Ogenyi","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina V.","family":"Zhilenkova","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy Elad","family":"Essogmo","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikenna Kingsley","family":"Uchendu","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"},{"name":"Medical Laboratory Science Department, Faculty of Health Science and Technology, College of Medicine, University of Nigeria, Enugu Campus, Enugu 410001, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6059-420X","authenticated-orcid":false,"given":"Yvan Sinclair Ngaha","family":"Tchawe","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"},{"name":"Department of Public Health, James Lind Institute, Rue de la Cit\u00e9 1, 1204 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3459-231X","authenticated-orcid":false,"given":"Akaye Madu","family":"Pascal","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3311-3290","authenticated-orcid":false,"given":"Natalia M.","family":"Nikitina","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4159-0994","authenticated-orcid":false,"given":"Onoja Solomon","family":"Oloche","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pavliv","sequence":"additional","affiliation":[{"name":"Department of General Medicine, I.M Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0658-9130","authenticated-orcid":false,"given":"Alexander S.","family":"Rusanov","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4840-4106","authenticated-orcid":false,"given":"Varvara D.","family":"Sanikovich","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6434-3155","authenticated-orcid":false,"given":"Yuliya N.","family":"Pirogova","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid N.","family":"Bagmet","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra V.","family":"Moiseeva","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina I.","family":"Sekacheva","sequence":"additional","affiliation":[{"name":"World-Class Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, Sechenov First Moscow State Medical University, Moscow 19991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"key":"ref_2","unstructured":"Eble, J.N., Saute, G., and Epstein, J. (2004). WHO Classification of tumours. Tumours of the Genitourinary and Male Genital Organs, IARC Press."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1200\/JCO.2005.07.055","article-title":"Prognostic value of histologic subtypes in renal cell carcinoma: A multicenter experience","volume":"23","author":"Patard","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"Vhl, the story of a tumour suppressor gene","volume":"15","author":"Gossage","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/14656566.2014.868436","article-title":"Axitinib for the treatment of advanced renal cell carcinoma","volume":"15","author":"Akaza","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1303989","article-title":"Pazopanib versus sunitinib in metastatic renal-cell carcinoma","volume":"369","author":"Motzer","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1510016","article-title":"Cabozantinib versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Choueiri","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(19)30735-1","article-title":"Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (tivo-3): A phase 3, multicentre, randomised, controlled, open-label study","volume":"21","author":"Rini","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 who classification of tumours of the urinary system and male genital organs-part a: Renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network (2016). Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med., 374, 135\u2013145.","DOI":"10.1056\/NEJMoa1505917"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Malouf, G.G., Comp\u00e9rat, E., Yao, H., Mouawad, R., Lindner, V., Rioux-Leclercq, N., Verkarre, V., Leroy, X., Dainese, L., and Classe, M. (2016). Unique transcriptomic profile of collecting duct carcinomas relative to upper tract urothelial carcinomas and other kidney carcinomas. Sci. Rep., 6.","DOI":"10.1038\/srep30988"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e987","DOI":"10.1016\/j.clgc.2017.04.012","article-title":"Genomic characterization of renal medullary carcinoma and treatment outcomes","volume":"15","author":"Carlo","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: Recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: Results from a large, multicenter study","volume":"27","author":"Heng","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and Transcriptomic Features of Response to Anti- PD-1 Therapy in Metastatic Melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1126\/science.1185837","article-title":"Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21","volume":"328","author":"Shields","year":"2010","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Miao","year":"2015","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Defi ciency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfi ler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMIC"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1038\/s41467-018-07767-w","article-title":"Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer","volume":"9","author":"Jia","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Becht, E., Giraldo, N.A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Selves, J., Laurent-Puig, P., Sautes-Fridman, C., and Fridman, W.H. (2016). Estimating the population abundance of tissue-infi ltrating immune and stromal cell populations using gene expression. Genome. Biol., 17.","DOI":"10.1186\/s13059-016-1070-5"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1074-7613(00)80531-2","article-title":"TECK: A novel CC chemokine specifi cally expressed by thymic dendritic cells and potentially involved in T cell development","volume":"7","author":"Vicari","year":"1997","journal-title":"Immunity"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2009-07-235721","article-title":"CC chemokine receptor 7 and 9 double-defi cient hematopoietic progenitors are severely impaired in seeding the adult thymus","volume":"115","author":"Krueger","year":"2010","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41416-020-0943-2","article-title":"EGFR\/Ras-induced CCL20 production modulates the tumour microenvironment","volume":"123","author":"Hippe","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: The cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.21037\/tcr-21-227","article-title":"Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the ADAMTS18 gene","volume":"10","author":"Xu","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12013-015-0694-5","article-title":"Curcumin Promotes Cell Cycle Arrest and Inhibits Survival of Human Renal Cancer Cells by Negative Modulation of the PI3K\/AKT Signaling Pathway","volume":"73","author":"Zhang","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"de Joode, K., van de Geer, W.S., van Leenders, G.J.L.H., Hamberg, P., Westgeest, H.M., Beeker, A., Oosting, S.F., van Rooijen, J.M., Beerepoot, L.V., and Labots, M. (2023). The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-37764-z"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Yang, Y.C., Lin, Y.W., and Lee, W.J. (2023). The RNA-binding protein KSRP aggravates malignant progression of clear cell renal cell carcinoma through transcriptional inhibition and post-transcriptional destabilization of the NEDD4L ubiquitin ligase. J. Biomed. Sci., 30.","DOI":"10.1186\/s12929-023-00949-9"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.7150\/ijbs.57802","article-title":"Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation","volume":"17","author":"Tang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_34","unstructured":"(2024, October 20). Canadian Cancer Statistics Advisory Committee Canadian Cancer Statistics 2019. Available online: http:\/\/cancer.ca\/Canadian-Cancer-Statistics-2019-EN."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.2018.79.1905","article-title":"Epidemiology and Risk Factors for Kidney Cancer","volume":"36","author":"Scelo","year":"2018","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal Cell Carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4161\/cbt.10.7.13247","article-title":"Signaling Pathways in Renal Cell Carcinoma","volume":"10","author":"Banumathy","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1464-410X.2012.10934.x","article-title":"Unclassified Renal Cell Carcinoma: A Report of 56 Cases","volume":"110","author":"Kirkali","year":"2012","journal-title":"BJU Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/bs.ai.2015.12.002","article-title":"Immune contexture, immunoscore, and malignant cell molecular subgroups for prognostic and theranostic classifications of cancers","volume":"130","author":"Becht","year":"2016","journal-title":"Adv. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1158\/2159-8290.CD-18-0957","article-title":"Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial","volume":"9","author":"Hakimi","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccell.2015.12.004","article-title":"An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma","volume":"29","author":"Hakimi","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_43","first-page":"543","article-title":"Immune checkpoint inhibitors for metastatic renal cell carcinoma: A systematic review and meta-analysis","volume":"11","author":"Massari","year":"2019","journal-title":"Immunotherapy"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","article-title":"Metabolic phenotype of clear-cell renal cell carcinoma: A contrast-enhanced computed tomography study","volume":"45","author":"Massari","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euf.2018.01.003","article-title":"Grading of Urothelial Carcinoma and The New \u201cWorld Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016\u201d","volume":"5","author":"Burger","year":"2019","journal-title":"Eur. Urol. Focus."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.it.2015.02.007","article-title":"T cell metabolic fitness in antitumor immunity","volume":"36","author":"Siska","year":"2015","journal-title":"Trends Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.urolonc.2016.10.006","article-title":"Emerging role of immunotherapy in urothelial carcinoma-Immunobiology\/biomarkers","volume":"34","author":"Sweis","year":"2016","journal-title":"Urol. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1158\/1078-0432.CCR-16-2848","article-title":"Tumor-Infiltrating and Peripheral Blood T Cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma","volume":"23","author":"Giraldo","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semcancer.2015.08.008","article-title":"Complexity in the Tumour Microenvironment: Cancer Associated Fibroblast Gene Expression Patterns Identify Both Common and Unique Features of Tumour-Stroma Crosstalk across Cancer Types","volume":"35","author":"Gandellini","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jare.2019.09.004","article-title":"The Role of Cancer-Associated Fibroblasts in Renal Cell Carcinoma. An Example of Tumor Modulation through Tumor\/Non-Tumor Cell Interactions","volume":"21","author":"Errarte","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1158\/1078-0432.CCR-20-4226","article-title":"Molecular Features of Cancer-Associated Fibroblast Subtypes and Their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance","volume":"27","author":"Galbo","year":"2021","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Saini, H., Rahmani Eliato, K., Veldhuizen, J., Zare, A., Allam, M., Silva, C., Kratz, A., Truong, D., Mouneimne, G., and LaBaer, J. (2020). The Role of Tumor-Stroma Interactions on Desmoplasia and Tumorigenicity within a Microengineered 3D Platform. Biomaterials, 247.","DOI":"10.1016\/j.biomaterials.2020.119975"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Liu, B., Chen, X., Zhan, Y., Wu, B., and Pan, S. (2021). Identification of a Gene Signature for Renal Cell Carcinoma\u2013Associated Fibroblasts Mediating Cancer Progression and Affecting Prognosis. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.604627"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Chen, L., Zhu, S., Liu, T., Zhao, H., Chen, P., Duan, Y., and Hu, R. (2021). Cancer Associated Fibroblasts Promote Renal Cancer Progression Through a TDO\/Kyn\/AhR Dependent Signaling Pathway. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.628821"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1158\/0008-5472.CAN-04-4406","article-title":"Stromal Cell-Derived Factor-1alpha and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: Von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor","volume":"65","author":"Zagzag","year":"2005","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Adair, T.H., and Montani, J.-P. (2010). Overview of Angiogenesis, Morgan & Claypool Life Sciences.","DOI":"10.4199\/C00017ED1V01Y201009ISP010"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor Angiogenesis: Causes, Consequences, Challenges and Opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/ki.2009.296","article-title":"The Role of VHL in Clear-Cell Renal Cell Carcinoma and Its Relation to Targeted Therapy","volume":"76","author":"Clark","year":"2009","journal-title":"Kidney Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15586\/jkcvhl.2017.88","article-title":"A Review of Von Hippel-Lindau Syndrome","volume":"4","author":"Varshney","year":"2017","journal-title":"J. Kidney Cancer VHL"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15586\/jkcvhl.v8i2.170","article-title":"Hypoxia-Inducible Factor-2\u03b1 as a Novel Target in Renal Cell Carcinoma","volume":"8","author":"Choi","year":"2021","journal-title":"J. Kidney Cancer VHL"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.critrevonc.2017.01.013","article-title":"Targeting HIF-2\u03b1 in Clear Cell Renal Cell Carcinoma: A Promising Therapeutic Strategy","volume":"111","author":"Grande","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Heidegger, I., Pircher, A., and Pichler, R. (2019). Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00490"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","article-title":"International variations and trends in renal cell carcinoma incidence and mortality","volume":"67","author":"Znaor","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1470-2045(18)30932-X","article-title":"Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: A retrospective analysis and multicentre validation study","volume":"20","author":"Wei","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Abah, M.O., Ogenyi, D.O., Zhilenkova, A.V., Essogmo, F.E., Ngaha Tchawe, Y.S., Uchendu, I.K., Pascal, A.M., Nikitina, N.M., Rusanov, A.S., and Sanikovich, V.D. (2025). Innovative Therapies Targeting Drug-Resistant Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC). Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26010265"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"eabb7422","DOI":"10.1126\/sciadv.abb7422","article-title":"ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12935-022-02763-z","article-title":"Role of CC-chemokine ligand 2 in gynecological cancer","volume":"22","author":"Zhang","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"C167","DOI":"10.1152\/ajpcell.00151.2022","article-title":"Physiology of chemokines in the cancer microenvironment","volume":"324","author":"Drouillard","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Nagaya, N., Lee, G.T., Horie, S., and Kim, I.Y. (2020). CXC Chemokine\/Receptor Axis Profile and Metastasis in Prostate Cancer. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.579874"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Susek, K.H., Karvouni, M., Alici, E., and Lundqvist, A. (2018). The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02159"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"107077","DOI":"10.1016\/j.intimp.2020.107077","article-title":"Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer","volume":"89","author":"Yu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.3748\/wjg.v24.i42.4738","article-title":"CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer","volume":"24","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: A web server for gene set cancer analysis","volume":"34","author":"Liu","year":"2018","journal-title":"Bioinformatics."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res."},{"key":"ref_75","first-page":"131","article-title":"The heidelberg classification of renal cell tumours","volume":"183","author":"Kovacs","year":"1997","journal-title":"J. Pathol. A J. Pathol. Soc. Gt. Br. Irel."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5858\/2010-0478-RAR.1","article-title":"Immunohistochemical diagnosis of renal neoplasms","volume":"135","author":"Truong","year":"2011","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel genomics-based taxonomy of renal cell carcinoma","volume":"14","author":"Chen","year":"2016","journal-title":"Cell Rep."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Ngaha, T.Y.S., Zhilenkova, A.V., Essogmo, F.E., Uchendu, I.K., Abah, M.O., Fossa, L.T., Sangadzhieva, Z.D., Sanikovich, V.D., Rusanov, A.S., and Pirogova, Y.N. (2023). Angiogenesis in Lung Cancer: Understanding the Roles of Growth Factors. Cancers, 15.","DOI":"10.3390\/cancers15184648"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal","volume":"83","author":"Kundra","year":"2023","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.3892\/ol.2016.5376","article-title":"Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP\/p53","volume":"12","author":"Xu","year":"2016","journal-title":"Oncol Lett."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.biopha.2017.07.148","article-title":"Curcumin enhances the radiosensitivity of renal cancer cells by suppressing NF-\u03baB signaling pathway","volume":"94","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Bule, P., Aguiar, S.I., and Aires-Da-Silva, F. (2021). Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189804"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Qu, G., Wang, H., Yan, H., Liu, G., and Wu, M. (2022). Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.857619"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.3390\/cancers13112849","article-title":"Circulating Levels of the Interferon-gamma-Regulated Chemokines CXCL10\/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy","volume":"13","author":"Esteban","year":"2021","journal-title":"Cancers"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2018.02.012","article-title":"Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity","volume":"109","author":"Karin","year":"2018","journal-title":"Cytokine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation-A target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/bjc.2015.193","article-title":"Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome","volume":"113","author":"Wightman","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Hong, S.H., Kang, N., and Kim, O. (2022). EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10\/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer. Cancers, 15.","DOI":"10.3390\/cancers15010124"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"77257","DOI":"10.18632\/oncotarget.12629","article-title":"PDGFR-alpha inhibits melanoma growth via CXCL10\/IP-10: A multi-omics approach","volume":"7","author":"Facchiano","year":"2016","journal-title":"Oncotarget"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1248\/bpb.b18-00538","article-title":"Forced Expression of CXCL10 Prevents Liver Metastasis of Colon Carcinoma Cells by the Recruitment of Natural Killer Cells","volume":"42","author":"Kikuchi","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e003521","DOI":"10.1136\/jitc-2021-003521","article-title":"Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma","volume":"9","author":"Reschke","year":"2021","journal-title":"J. Immunother. Cancer."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Zhang, L., Zhang, M., Wang, L., Li, J., Yang, T., Shao, Q., Liang, X., Ma, M., Zhang, N., and Jing, M. (2021). Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated with Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.694664"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"21809","DOI":"10.18632\/aging.103999","article-title":"CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients","volume":"12","author":"Liu","year":"2020","journal-title":"Aging"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.7150\/ijbs.74647","article-title":"Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma","volume":"18","author":"Xu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Pichler, R., Siska, P.J., Tymoszuk, P., Martowicz, A., Untergasser, G., Mayr, R., Weber, F., Seeber, A., Kocher, F., and Barth, D.A. (2023). A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1095195"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.21037\/jtd-23-227","article-title":"Increased TIM-3 expression in tumor-associated macrophages predicts a poorer prognosis in non-small cell lung cancer: A retrospective cohort study","volume":"15","author":"Zhang","year":"2023","journal-title":"J. Thorac. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Kadomoto, S., Izumi, K., Hiratsuka, K., Nakano, T., Naito, R., Makino, T., Iwamoto, H., Yaegashi, H., Shigehara, K., and Kadono, Y. (2019). Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 axis. Cancers, 12.","DOI":"10.3390\/cancers12010089"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Ozcelik, A., Abas, B.I., and Erdogan, O. (2022). On-Chip Organoid Formation to Study CXCR4\/CXCL-12 Chemokine Microenvironment Responses for Renal Cancer Drug Testing. Biosensors, 12.","DOI":"10.3390\/bios12121177"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0094-0143(05)70203-2","article-title":"Diagnosis and classification of renal cell carcinoma","volume":"26","author":"Bostwick","year":"1999","journal-title":"Urol. Clin. N. Am."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0094-0143(05)70205-6","article-title":"Risk and prognosis in renal neoplasms: A pathologist\u2019s prospective","volume":"26","author":"Bonsib","year":"1999","journal-title":"Urol. Clin. N. Am."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/CCO.0000000000000512","article-title":"The tumor microenvironment in renal cell cancer","volume":"31","author":"Mier","year":"2019","journal-title":"Curr. Opin. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Essogmo, F.E., Zhilenkova, A.V., Tchawe, Y.S.N., Owoicho, A.M., Rusanov, A.S., Boroda, A., Pirogova, Y.N., Sangadzhieva, Z.D., Sanikovich, V.D., and Bagmet, N.N. (2023). Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines. Cancers, 15.","DOI":"10.3390\/cancers15225383"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/bcr3665","article-title":"C-X-C motif chemokine 12\/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment","volume":"16","author":"Wani","year":"2014","journal-title":"Breast Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.semcancer.2022.03.022","article-title":"Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer","volume":"86","author":"Ganguly","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"A025","DOI":"10.1158\/2326-6074.TUMIMM24-A025","article-title":"Abstract A025: Novel workflow for characterizing T-cell functional heterogeneity in response to checkpoint inhibitors","volume":"12","author":"Yee","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e20201329","DOI":"10.1084\/jem.20201329","article-title":"STARTRAC analyses of scRNAseq data from tumor models reveal T cell dynamics and therapeutic targets","volume":"218","author":"Bhatt","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1073\/pnas.1818488116","article-title":"Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRV\u03b41 and TCRV\u03b42 \u03b3\u03b4 T lymphocytes","volume":"116","author":"Pizzolato","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Lyu, J., Xu, X., and Chen, C. (2024). A convenient single-cell newly synthesized transcriptome assay reveals FLI1 downregulation during T-cell activation. bioRix.","DOI":"10.1101\/2024.08.22.609222"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00000478-199706000-00001","article-title":"Papillary (chromophil) renal cell carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases","volume":"21","author":"Amin","year":"1997","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_113","first-page":"537","article-title":"Papillary renal cell carcinoma: A clinicopathologic and immunohistochemical study of 105 tumors","volume":"10","author":"Delahunt","year":"1997","journal-title":"Mod. Pathol. Off. J. United States Can. Acad. Pathol. Inc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6161\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:59:22Z","timestamp":1760032762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":113,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26136161"],"URL":"https:\/\/doi.org\/10.3390\/ijms26136161","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}